Wells Fargo lowered the firm’s price target on KKR Real Estate Finance (KREF) to $11 from $14 and keeps an Overweight rating on the shares ...

KKR & Co. Inc. Q1 on May 1 could surprise positively amid strategic moves like the Biotage acquisition. Click here to see why KKR fundamentals offer long-term potential.

We recently compiled a list of the 13 Best Aggressive Growth Stocks to Buy Now. In this article, we are going to take a look ...

Citizens JMP lowered the firm’s price target on KKR Real Estate Finance (KREF) to $12 from $13 and keeps an Outperform rating on the shares.

KKR (KKR) is opting for direct lenders in financing its acquisition of Karo Healthcare, rather than banks it had chosen to ...

The firm, which has once again topped the latest AmLaw 100 ranking, has secured a series of sub-one billion dollar U.K. and ...

KKR to pay 33% premium for Datagroup shares Datagroup to delist, expected in Q3 2025 Company's shares jump around 31% Under the terms of the agreement - the latest in a flurry of acquisitions by ...

COPENHAGEN, April 22 (Reuters) - Sweden's Biotage (BIOT.ST), opens new tab said on Tuesday that KKR had made a cash offer for the Swedish biotechnology firm, valuing it at around 11.6 billion ...

The firm, which has once again topped the latest Am Law 100 ranking, has secured a series of sub-one billion dollar U.K. and ...

In this article, we are going to take a look at where KKR & Co. Inc. (NYSE:KKR) stands against Prem Watsa's other stock picks. Momentum and technology stocks have dominated the markets over the ...

(KREF) ...

Private equity firm KKR & Co. continued its spurt of acquisitions amid widespread market volatility by making a take-private offer for Swedish life sciences group Biotage AB for 11.6 billion ...